WalterK.KraftMDMS, FACP

PubMed

• Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS).
  Selvage, E., Ng, S., Chervoneva, I., Maisel, B., Adeniyi-Jones, S., Kraft, W.> ;Journal of Perinatology. 2024 Feb 16
• 2 citations
  Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial.
  Gary Peltz, Lauren M Jansson, Carol Cohane, David Drover, Steven Shafer, Meiyue Wang, Manhong Wu, Priya Jegatheesan, Cynthia Argani, Salwa Khan, Walter K Kraft, Susan ...> ;Journal of Perinatology. 2023 Mar 1
• 1 citations
  Platelet protease activated receptor 4 (PAR 4) receptor genotype is associated with an increased risk of preterm birth.
  Rupsa C Boelig, Tara J Cahanap, Lin Ma, Tingting Zhan, Vincenzo Berghella, Joanna S Y Chan, Walter K Kraft, Steven E Mckenzie> ;Journal of Thrombosis and Haemostasis. 2022 Oct 1
• 1 citations
  Clinical Pharmacology and the Best Use of Public Research Investment.
  Walter K Kraft> ;Clinical Pharmacology and Therapeutics. 2022 Jun 1
• 1 citations
  Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients.
  Holly Mansell, Ahmed Shoker, Jane Alcorn, Mark E Fenton, Julian S Tam, William Semchuk, Babar Bashir, Walter K Kraft, Shenzhen Yao, James D Douketis> ;Clinical and Translational Science. 2022 Jul 1
• 1 citations
  Apixaban Discontinuation for Invasive Or major Surgical procedures (ADIOS): A prospective cohort study.
  Geno J. Merli, Walter K. Kraft, Luis H. Eraso, Taki Galanis, Lynda Thomson, Geoffrey Ouma, Eugene R. Viscusi, Jerald Z. Gong, Edwin Lam> ;Vascular Medicine. 2021 Nov 22
• 3 citations
  Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis.
  Edwin Lam, Yi Ting Kayla Lien, Walter K. Kraft, Douglas F. Stickle, Beth Piraino, Jingjing Zhang> ;Clinical and Translational Science. 2021 Nov 9
• 6 citations
  Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers.
  David S. Weinberg, Nathan R. Foster, Gary Della'Zanna, Ryan McMurray, Walter K. Kraft, Angela Pallotto, David Kastenberg, Leo Katz, Christopher H. Henry, Stephanie Mol...> ;Cancer Biology & Therapy. 2021 Oct 10
• 4 citations
  Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.
  Darla K. Liles, Nirmish Shah, Brigid Scullin, Victor R. Gordeuk, Wally R. Smith, Julie Kanter, Maureen Achebe, Ralph V. Boccia, Shelley E. Crary, Walter K. Kraft, Nata...> ;British Journal of Haematology. 2021 Oct 5
• 13 citations
  Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.
  Lori A. Devlin, Leslie Young, Walter K. Kraft, Elisha M. Wachman, Adam J. Czynski, Stephanie L. Merhar, Theresa Winhusen, Hendrée E. Jones, Brenda B. Poindexter, Laure...> ;Journal of Perinatology. 2021 Sep 23
• 1 citations
  Longitudinal evaluation of azithromycin and cytokine concentrations in amniotic fluid following one-time oral dosing in pregnancy.
  Rupsa C. Boelig, Edwin Lam, Ankit K. Rochani, Gagan Kaushal, Amanda Roman, Walter K. Kraft> ;Clinical and Translational Science. 2021 Jul 26
• 1 citations
  Seeking Similarities Rather Than Differences With Adults to Aid in Therapeutic Advancement for Children.
  Mara L. Becker, Walter K. Kraft> ;Clinical Pharmacology and Therapeutics. 2021 Jul 1
• 3 citations
  Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome.
  Rena Eudy-Byrne, Nicole R. Zane, Marc R. Gastonguay, Ana Ruiz-Garcia, Gagan Kushal, Walter K. Kraft> ;Clinical and Translational Science. 2021 Sep 16
• 1 citations
  Stability-indicating LC-MS Method for Determination of Stability of Extemporaneously Compounded Buprenorphine Oral Syringes for Neonatal Abstinence Syndrome.
  Ankit K. Rochani, Vinh Nguyen, Robin Becker, Walter K. Kraft, Gagan Kaushal> ;The Journal of Pediatric Pharmacology and Therapeutics. 2021 May 1
• 3 citations
  Is Maternal Methadone Dose Associated with the Severity of Neonatal Abstinence Syndrome
  Jessica Smith, Margaret A. Lafferty, Rupsa C. Boelig, David Carola, Walter K. Kraft, Jay S. Greenspan, Zubair H. Aghai> ;American Journal of Perinatology. 2020 Dec 15
• 17 citations
  Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults.
  K Chris Min, Walter K. Kraft, Phung Bondiskey, Francheska Colon-Gonzalez, Wen Liu, Jialin Xu, Deborah Panebianco, Lori A. Mixson, Marissa F. Dockendorf, Catherine Z. M...> ;Clinical and Translational Science. 2021 Mar 1
• 4 citations
  Twice-Daily Doravirine Overcomes the Interaction Effect from Once-Weekly Rifapentine and Isoniazid in Healthy Volunteers.
  Edwin Lam, Joseph W. Schaefer, Richard Zheng, Tingting Zhan, Walter K. Kraft> ;Clinical and Translational Science. 2020 Nov 1
• 10 citations
  Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males.
  Wendy Ankrom, Phung Bondiskey, Chi-Chung Li, John Palcza, Wen Liu, Marissa F. Dockendorf, Catherine Z. Matthews, Deborah Panebianco, Tom Reynders, John A. Wagner, Abhi...> ;Clinical and Translational Science. 2020 May 1
• 10 citations
  Development of an abbreviated symptom score for the neonatal abstinence syndrome.
  Inna Chervoneva, F Blanco, Walter K. Kraft> ;Journal of Perinatology. 2020 Feb 19
• 13 citations
  Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.
  Edwin Lam, Yi Ting Kayla Lien, Walter K. Kraft, Beth Piraino, Valvanera Vozmediano, Stephan Schmidt, Jingjing Zhang> ;Peritoneal Dialysis International. 2020 Feb 17
• 5 citations
  Simultaneous quantitative LC-MS method of ketamine, midazolam and their metabolites (dehydronorketamine, norketamine and 1hydroxymidazolam) for its application in pati...
  Ankit K. Rochani, Edwin Lam, Julian Tanjuakio, Hitoshi Hirose, Walter K. Kraft, Gagan Kaushal> ;Journal of Pharmaceutical and Biomedical Analysis. 2020 Jan 30
• 41 citations
  Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil
  Jacqueline B. McCrea, Sreeraj Macha, Adedayo Adedoyin, William L. Marshall, Karsten Menzel, Carolyn R. Cho, Fang Liu, Tian Zhao, Vanessa Levine, Walter K. Kraft, Esthe...> ;Journal of Clinical Pharmacology. 2019 Oct 1
• 7 citations
  No meaningful drug interactions with doravirine, lamivudine and tenofovir disoproxil fumarate coadministration.
  Matt S. Anderson, Jocelyn Gilmartin, Li Fan, Ka Lai Yee, Walter K. Kraft, Ilias Triantafyllou, Christina Reitmann, Ying Guo, Rachael Liu, Marian Iwamoto> ;Antiviral Therapy. 2019 Jan 1
• 4 citations
  Could Postnatal Age–Related Uridine Diphosphate Glucuronic Acid Be a Rate-Limiting Factor in the Metabolism of Morphine During the First Week of Life?
  Tao Liu, Tamorah R Lewis Md PhD, Jason N. Moore, Walter K. Kraft, Estelle B. Gauda, David Alan Sartori, David E. Moody, Jogarao V. S. Gobburu, Vijay Ivaturi> ;CPT. 2019 Jul 1
• 14 citations
  Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy.
  Edwin Lam, Babar Bashir, Mark Chaballa, Walter K. Kraft> ;Expert Review of Clinical Pharmacology. 2019 Jul 4
• Join now to see all

Journal Articles

• “How to Help Your Patients Quit Smoking”  
  Kraft W, Steinberg M, Delnevo C., IM: Internal Medicine, 3/1/1999

Books/Book Chapters

• Medical Management of the Surgical Patient 
  Chapter: “Managing Medication in the Perioperative Period” 
  Kraft WK, Diemer GEditors: Merli G, Weitz H.Saunders, Philadelphia, PAEdition 3rd,2008
• Pharmacology and Therapeutics: Principles to Practice 
  Chapter: Asthma and COPD. 
  Kraft WK, Leone FEditors: Waldman SA, Terzic A.Saunders ElsevierEdition 1st,2008
• Pharmacology and Therapeutics: Principles to Practice 
  Chapter: Peptic Ulcer Disease and Reflux. 
  Mejia A, Kraft WKEditors: Waldman SA, Terzic A.Saunders ElsevierEdition 1st,2008
• Clinical Immunology and Allergy in Medicine 
  Chapter: “Effects of Concomitant Administration of an Aluminum- and Magnesium-containing Antacid on the Absorption Profile of Loratadine”, Chapter 97 
  Greenberg HE , Mehdi F, VanBuren S, Waldman SA, Pequignot E, Kraft WKEditors: Marone G.JGC, Naples, Italy2003
• Essential Evidence Plus 
  Chapter: Asthma, Chronic Treatment. 
  Kraft WK, Desimone DCEditors: Ebell MH.John Wiley and Sons, Hoboken, NJEdition 1st,
• Essential Evidence Plus 
  Chapter: Neonatal Abstinence Syndrome. 
  Kraft WKEditors: Ebell MH.John Wiley and Sons, Hoboken, NJEdition 1st,
• Essential Evidence Plus 
  Chapter: Opioid Overdose. 
  Kraft WKEditors: Ebell MH.John Wiley and Sons, Hoboken, NJEdition 1st,
• Join now to see all

Abstracts/Posters

• Ethanol Pharmacokinetics in Neonates Secondary to Medication Administration
  Marek E, Adeniyi-Jones SC, Roke L, DeCerbo TE, Cordell RL, Monks PS, Kraft WK, American Academy of Pediatrics, Washington, DC, 10/2015
• No Evidence of a Drug-Drug Interaction between Letermovir (MK-8228) and Mycophenolate Mofetil.
  Marshall WL, Badshah C, Liu F, Kraft WK, Gonzales-Colon F, van Schanke A, Udo de Haes J, Kantesaria B, Cho C, Hulskotte E, Butterton JR, Marcantonio EE., ASMBT, San Diego, 2/2015
• Neonatal abstinence syndrome (NAS) in methadone exposed infants: role of genetic variability.
  Fielder AL, Coller JK., Hutchinson M, Haslam RR, Lu N, Adeniyi-Jones S, Ehrlich M, Kraft WK, Accepted for presentation at CPDD Scientific Meeting, 6/18/2014
• Effect of Ritonavir (RTV) and Tenofovir (TDF) on the Pharmacokinetics of MK-1439, a Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI).
  Anderson MS, Gilmartin J, Mitselos A, Laethem T, van Bortel L, Kraft WK, Guo Y, Dockendorf MF, Wagner JA, Butteron JR, Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC 2013), Denver, CO, 10/11/2013
• The Impact of Community Use of Novel Oral Anticoagulants on an Academic Medical Center.
  Eraso EH, Galanis T, Kipp K, Kraft WK , Palladino M, Perez A, Ferebee–Spruill K, Merli G, Swift B, Thomson L, Vining B, The Anticoagulation Forum, Phoenix, AZ, 5/5/2013
• Developing a Transition of Care Model to Safely and Effectively Manage Complex Vascular Diseases.
  Palladino M, Thomson L, Eraso EH, Merli G, Galanis T, Kraft WK , Perez A, The Anticoagulation Forum, Phoenix, AZ, 5/5/2013
• A Potential Interaction between Melatonin and Warfarin: Is It Worth Losing Sleep Over?
  D’Ascenzo JD, Franta KJ, Kraft WK, Thomson LJ, ASHP (American Society of Health System Pharmacists) Midyear Clinical Meeting, Las Vegas, NV, 12/5/2012
• Effect of Concomitant Medications Affecting Gastric pH and Motility on Posaconazole (POS) Tablet Pharmacokinetics (PK).
  Kraft WK, Chang P, van Iersel MLPS, Waskin H, Krishna G, Kersemaekers W, ICAAC meeting, San Francisco, CA, 9/1/2012
• Characterization of venous thromboembolism stratified by medical thromboprophylaxis: Experience in a free standing neurosciences hospital.
  Perez A, Galanis T, Eraso EH, Kraft WK, Templin M, Louis DZ, Merli GJ, Accepted for presentation at the Society for Vascular Medicine meeting, Minneapolis, MN, 6/14/2012
• Population pharmacokinetic modeling of buprenorphine in newborns with neonatal abstinence syndrome.
  Wu D, Kraft WK , Ehrlich ME, Dombrowsky E, Barrett JS, American Society for Clinical Pharmacology and Therapeutics meeting, Washington, DC, 3/1/2012
• Safety and Tolerability of Single Dose Green Tea Extract Epigallocatechin Gallate (EGCG) in Cirrhotic and Non-cirrhotic Hepatitis C Patients.
  Halegoua-De Marzio D, Kraft WK, Greenbaum L, Xie Y, Hawke R, Navarro VN, Digestive Diseases Week Meeting, San Diego, CA, 1/1/2012
• Comparing Prognosis Estimates of Cancer Patients and Their Oncologists.
  Gentzler R, Kraft WK, Leiby B, Filicko-O'Hara J, 2012 ASCO Annual Meeting Proceedings I, 1/1/2012
• “Comparison of Transdermal and Oral Estrogen Hormone Therapy and Risks of Venous Thromboembolic Events”
  Omicioli V, Daskalakis C, Louis D, Rabinowitz C, Maio V, Kraft WK, 20th Annual Meeting of the North American Menopause Society, San Diego, CA, 9/30/2009
• “BMS-790052 is a First-in Class Potent Hepatitis C Virus (HCV) NS5A Inhibitor for Patients with Chronic HCV Infection: Results from a Proof-of-concept Study.”
  Nettles RE, Chien C, Chung E, Persson A, Gao M, Belema M, Meanwell N, DeMicco M, Marbury T, Goldwater P, Northup P, Coumbis J, Kraft WK, Charlton M, Lopez-Talavera JC,..., 13th International Symposium on Viral Hepatitis and Liver Disease, Washington, DC, 3/1/2009
• "BMS-790052 is a First-in Class Potent Hepatitis C Virus (HCV) NS5A Inhibitor for Patients with Chronic HCV Infection: Results from a Proof-of-concept Study.”
  Nettles RE, Chien C, Chung E, Persson A, Gao M, Belema M, Meanwell N, DeMicco M, Marbury T, Goldwater P, Northup P, Coumbis J, Kraft WK, Charlton M, Lopez-Talavera JC,..., The Asian Pacific Association for the Study of the Liver Meeting, Hong Kong, 2/1/2009
• "Safety, Tolerability and Antiviral Activity of MK-7009, a Novel Inhibitor of the Hepatitis C Virus NS3/4A Protease, in Patients with Chronic HCV Genotype 1 Infection.”
  Lawitz E, Sulkowski M, Jacobson I, Faruqui S, Kraft W, Maliakkal B, Al-Ibrahim, ReemGhalib M, Gordon S, Kwo P, Rockstroh J, Miller M, Hwang P, Gress J, Quirk E, American Association for the Study of Liver Diseases meeting, San Francisco, CA, 11/1/2008
• “BMS-790052 is a Potent Hepatitis C Virus (HCV) NS5A Inhibitor for Patients with Chronic HCV Infection: Results from a Proof-of-concept Study"
  Nettles RE, Chien C, Chung E, Persson A, Gao M, Belema M, Meanwell N, DeMicco M, Marbury T, Goldwater P, Northup P, Coumbis J, Kraft WK, Charlton M, Lopez-Talavera JC,..., American Association for the Study of Liver Diseases meeting, San Francisco, CA, 11/1/2008
• “Laropiprant Does Not Alter the Antiplatelet Activity of Aspirin.”
  Schwartz J, Mabalot J, Luo L, Dallob A, Kraft WK, Wagner J, Lai E, American Heart Association meeting, New Orleans, LA, 11/1/2008
• ”Sublingual bioavailability of buprenorphine in newborns with neonatal abstinence syndrome--a case study on physiological and developmental changes using SIMCYP.”
  Wu D, Kraft WK , Ehrlich ME, Barrett JS, American College of Clinical Pharmacology meeting, Philadelphia, PA, 9/1/2008
• "First Use of Sublingual Buprenorphine for Treatment of the Neonatal Abstinence Syndrome: A Randomized Trial.”
  Kraft WK , Dysart K, Gibson E, Greenspan J, Damle V, Kaltenbach K, LaRusso J, Moody D. Ehrlich M, Society for Pediatric Research Meeting, Hawaii, 5/1/2008
• ”Cough Response To Inhaled Capsaicin Following A Blinded, Oral, Single Dose Of Codeine, Dextromethorphan, Or Placebo In Healthy Males.”
  Gong JP, Burke J, Blanchard RL, Dicpinigaitis P, Yan X, Palcza J, Bradstreet TE, Kraft WK, Clinical Pharmacology and Therapeutics; Poster at the American Society for Clinical Pharmacology and Therapeutics meeting, Orlando, FL, 4/1/2008
• “Prophylaxis, screening and the incidence of periprocedural deep vein thrombosis among neurosurgical patients at an academic medical center”.
  Henwood PC, Merli GJ, Rosenwasser RH, Tzanis G, Thomson L, Fink J, Kraft WK, Society for Vascular Medicine and Biology's 18th Annual Scientific Sessions, Baltimore, MD, 6/1/2007
• “Low molecular weight heparin, the most cost effective treatment of venous thromboembolism”
  Hayes E, Almario C, Pizzi L, Kraft WK, Baxter J, Society for Maternal Fetal Medicine 27th Annual Scientific Meeting, San Francisco, CA, 2/1/2007
• The Pharmacokinetics Of Taurolidine Metabolites In Healthy Volunteers"
  Li G, Waldman SA, Greenberg HE, Kraft WK, Poster at the American College of Clinical Pharmacology meeting, Cambridge, MA, 9/1/2006
• ”Pharmacokinetics (PK) of Multiple Oral Doses of Desloratadine (DCL) and Fexofenadine (FEX) in a Population of Healthy Adults Identified Phenotypically as Desloratadin...
  Kraft WK, Blum RA, Frick GS, Vitow C, Stewart JA, Kovacs SJ, Clinical Pharmacology and Therapeutics; Poster at the American Society for Clinical Pharmacology and Therapeutics meeting, Orlando, FL, 3/1/2005
• Join now to see all

Lectures

• “How the IRB Looks at Medical Education Projects”. 
  Thomas Jefferson University/Hospital - 3/13/2014
• Speaker, “Pharmacologic Therapies for the Neonatal Abstinence Syndrome”. 
  Cincinnati Children’s Hospital, University of Cincinnati School of Medicine - 3/6/2014
• Faculty Speaker, "Toxidromes: Making the best treatment decisions" 
  1/22/2014
• "Challenges Facing Physician Scientists in the 21st Century" 
  Thomas Jefferson University/Hospital - 9/28/2013
• "How to Build a Career in Clinical Research” 
  Thomas Jefferson University/Hospital - 9/19/2013
• Faculty Speaker, "Examining the Evidence: Controversies in the Pharmacologic Management" 
  7/14/2013
• Speaker, "Controversies in the Treatment of Neonatal Abstinence Syndrome: Methadone, Morphine, Buprenorphine, Clonidine, Phenobarbital or Bust?" 
  Washington, DC - 5/30/2013
• Speaker, "Pharmacology Review: Risks and Benefits of Methadone, Morphine, Buprenorphine, Clonidine, and/or Phenobarbital". 
  Washington, DC - 5/29/2013
• Faculty Speaker, "Substance Exposure 101: Frequency and Neonatal Impact by Agent" 
  5/15/2013
• Speaker, "“Novel Therapies in Treatment of Neonatal Abstinence Syndrome" 
  Nemours/A.I. duPont Hospital for Children, Wilmington, DE - 2/25/2013
• Speaker, "Best Practices and Resources for Preventing Dual Enrollment in Clinical Trials" 
  New Brunswick, NJ - 11/16/2012
• Speaker and Discussant, "Bridging Adult and Pediatric Conditions: Biomarkers in Pediatric Drug Development" 
  Los Angeles, CA - 11/4/2012
• Speaker and Discussant, "Safety Challenges and Developing Models for Emergency Response Coverage in First in Human Trials" 
  San Diego, CA - 9/23/2012
• "Optimizing Pediatric Drug Development” 
  Thomas Jefferson University - 5/9/2012
• Speaker and Discussant, "Addressing Current Recruitment and Retention Challenges within Pediatric Clinical Trials" and "Optimizing Pediatric Drug Development" 
  Philadelphia, PA - 5/3/2012
• Speaker and Discussant, "The Human Research Participant in Today’s Early Phase Research & Updates on National Registry Initiatives" 
  Bethesda, MD - 4/26/2012
• Symposium Chair and Presenter, "Optimizing Pediatric Therapeutics by Applying Lessons from Adult Drug Development" 
  Washington, DC - 3/16/2012
• “Obtaining Industry Support of Investigator Initiated Research Proposals” 
  Thomas Jefferson University/Hospital - 1/10/2012
• Visiting Speaker, "Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome" 
  12/20/2011
• “New Agents, New Horizons in the Pharmacologic Management of Substance - Exposed Newborns” 
  Washington, DC - 6/1/2011
• "Phase 1 Research and Healthy Volunteers" 
  Cooper University Hospital, Camden, NJ - 2/24/2011
• Featured Speaker, “Future Trends in the Treatment of Neonatal Abstinence Syndrome” 
  Alexandria, VA - 6/24/2010
• “Venous Thromboembolism Prophylaxis in the Neurosurgical Patient” 
  Thomas Jefferson University/Hospital - 6/12/2009
• “Phase 1 Trials in Healthy Volunteers” 
  Lambertville, NJ - 4/8/2009
• Visiting FDA lecturer, “Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome” 
  White Oak, MD - 9/12/2008
• Join now to see all

Other

• Quoted in article "Newborns Hooked on Moms' Painkillers Go Through Agonizing Withdrawal" 
  ABCnews.com
  11/14/2011
• Quoted in "Doctor At Jefferson Works To Speed Up Process Of Weaning Newborns Off Drugs" 
  KYW Newsradio
  11/11/2011
• Quoted in article "Treating the tiniest addicts" 
  The Buffalo News
  6/1/2011
• Quoted in article "Obstructive Sleep Apnea" 
  ACP Hospitalist
  4/1/2011
• Quoted in article “Study Finds Opioid Overdose Incidence Tied to Higher Prescribed Dosages” 
  Pain Medicine News
  4/1/2010
• Acid Peptic Diseases: Pharmacological Approach To Treatment. 
  Kraft WK, Mejia A, Expert Review in Clinical Pharmacology
  1/1/2009
• Aprepitant For The Prevention Of Nausea And Vomiting Associated With Chemotherapy And Postoperative Recovery. 
  LaRusso J, Waldman SA, Kraft WK, Expert Review in Clinical Pharmacology
  1/1/2008
• Bridging the Therapeutic Continuum of Drug Development, Regulation and Use. 
  Kraft WK, Waldman SA, Expert Review in Clinical Pharmacology
  1/1/2008
• The Bronchodilators. 
  Kraft WK, Frick GS, Hospital Practice Pulmonary Board Review
  4/1/2007
• “Managing preoperative medications”. 
  Marian Freedman [author] Steven L Cohn, Walter K. Kraft, Karen F. Mauck [consultants], Patent Care
  10/1/2006
• “Thomas Jefferson University K30 Program Externship: Critical Review of the Medical Literature at The Annals Of Internal Medicine.” 
  Kraft WK, Waldman SA, Weinberg D, Laine C, Clinical Research Perspective
  3/1/2004
• Thomas Jefferson University Self Directed Intranet Module #09: “Evidence-Based Medicine” 
  Kraft WK
• Internet Video Highlighting the Drug Development Process (Clinical Trials) 
  
  http://www.innovation.org/index.cfm/InsideDrugDiscovery
• Join now to see all